(Press-News.org)
Measuring blood flow in the brain is critical for responding to a range of neurological problems, including stroke, traumatic brain injury (TBI) and vascular dementia. But existing techniques, including magnetic resonance imaging and computed tomography, are expensive and therefore not widely available.
Researchers from the USC Neurorestoration Center and the California Institute of Technology (Caltech) have built a simple, noninvasive alternative. The device takes a technique currently used in animal studies known as speckle contrast optical spectroscopy (SCOS) and adapts it for potential clinical use in humans. It works by capturing images of scattered laser light with an affordable, high-resolution camera.
“It’s really that simple. Tiny blood cells pass through a laser beam, and the way the light scatters allows us to measure blood flow and volume in the brain,” said Charles Liu, MD, PhD, professor of clinical neurological surgery, urology and surgery at the Keck School of Medicine of USC, director of the USC Neurorestoration Center and co-senior author of the new research.
The device has already been tested with humans in small proof of concept studies demonstrating the tool’s utility for assessing stroke risk and detecting brain injury. In the current study, Liu and his team sought to confirm that SCOS is truly measuring blood flow in the brain, rather than in the scalp, which also contains many blood vessels. The question has long plagued researchers who use light-based technology to visualize the brain.
Liu’s team took an innovative approach: By temporarily blocking blood flow to the scalp, they confirmed that SCOS readings were indeed measuring signals from blood vessels in the brain. Readings from 20 participants showed that positioning the detector at least 2.3 centimeters away from the laser source provided the clearest measurement of brain blood flow. The study, funded in part by the National Institutes of Health, the Alfred Mann Foundation and the USC Neurorestoration Center, was just published in the journal APL Bioengineering.
“For the first time in humans, this experimental evidence shows that a laser speckle optical device can probe beyond the scalp layers to access cerebral signals,” said Simon Mahler, PhD, who is now an assistant professor in the Department of Biomedical Engineering at the Stevens Institute of Technology and one of the paper’s coauthors. “This is an important step toward using SCOS to non-invasively measure blood flow in the brain.”
Tracking brain blood flow
For years, researchers measuring brain signals with light-based technology, such as lasers and fiber optics, have used statistical simulations to estimate which signals originate in the brain versus the scalp. The USC Neurorestoration Center team found a direct way to test the difference, thanks to a collaboration between surgeons, engineers and neurologists.
“I perform surgeries to increase blood flow in the brain, and many of these involve temporarily stopping blood flow in the scalp,” said Jonathan Russin, MD, now professor and chief of neurosurgery at the University of Vermont, who continues to collaborate with the USC Neurorestoration Center. “That gave us a simple way to test the technology—by creating a change that affected only the scalp’s circulation while leaving the brain’s blood flow untouched.”
In 20 participants, the researchers temporarily stopped blood flow to the scalp, then collected a series of SCOS readings. By gradually moving the detector further from the head, they captured signals reaching progressively deeper towards the brain. They found that positioning the detector 2.3 centimeters from the head allowed them to measure brain blood flow while minimizing interference from the scalp.
The findings confirm the utility of SCOS for non-invasively detecting brain blood flow and provide important guidance for other researchers working with light-based technology, Liu said.
Bringing SCOS to patients
Beyond advancing research, the study helps confirm the clinical potential of SCOS for detecting and responding to stroke, brain injury and dementia. Because all of the team’s research has been done with humans, the tool is poised for rapid translation from the lab to the clinic.
“We look directly at humans in essentially the same way the tool will be applied, so there’s nothing lost in translation,” Liu said. “We are never more than one step away from the problem we’re trying to solve.”
The technique is already being used by some of the team’s collaborators to help diagnose stroke and TBI. Next, the researchers will continue to refine the technology and software, working to improve the resolution of images and the quality of data extracted from readings.
“With the knowledge that we’re now measuring exactly what we intend to measure, we’re also going to expand our testing of this technique with patients in clinical settings,” Liu said.
About this research
In addition to Liu, Mahler and Russin, the study’s other authors are Aidin Abedi and Yu Tung Lo from the USC Neurorestoration Center, Department of Neurological Surgery, Keck School of Medicine of USC, University of Southern California; Patrick D. Lyden from the Zilkha Neurogenetic Institute and Department of Neurology, Keck School of Medicine of USC, University of Southern California; and Yu Xi Huang, Maya Dickson and Changhuei Yang from the Department of Electrical Engineering, California Institute of Technology.
This work was supported by the National Institutes of Health [5R21EY033086-02]; the Caltech Center for Sensing to Intelligence [13630012]; the USC Neurorestoration Center; the Alfred Mann Foundation; and the 2024 SPIE-Franz Hillenkamp Postdoctoral Fellowship.
END
About The Study: Among privately insured individuals, the use of colonoscopy and fecal immunochemical tests decreased after the COVID-19 pandemic while stool DNA test use increased, with differences by sex, area-level socioeconomic status, and metropolitan area residence.
Corresponding Author: To contact the corresponding author, Sunny Siddique, MD, PhD, email sunny.siddique@yale.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.38578)
Editor’s Note: Please see the article for additional information, including ...
WASHINGTON, Oct. 21, 2025 — Seaweed is found around the world. In fact, the name “seaweed” comprises a diverse range of species, from microscopic phytoplankton to the giant forests found in various bodies of water.
Seaweed species aren’t just crucial parts of marine ecosystems, though; they also provide numerous health benefits for humans and have been dubbed a superfood by marketing companies, a term used to encompass healthy, nutrient-rich foods.
In Biointerphases, an AVS journal published by AIP Publishing, researchers from Oregon State University found yet another ...
PROVIDENCE, R.I. [Brown University] — As more people turn to ChatGPT and other large language models (LLMs) for mental health advice, a new study details how these chatbots — even when prompted to use evidence-based psychotherapy techniques — systematically violate ethical standards of practice established by organizations like the American Psychological Association.
The research, led by Brown University computer scientists working side-by-side with mental health practitioners, showed that chatbots are prone to a variety of ethical violations. Those include inappropriately navigating crisis situations, ...
People who use both cannabis and tobacco show distinct brain changes compared to those who use cannabis alone, according to a new study led by McGill University researchers at the Douglas Research Centre.
The finding may help explain why people who use both cannabis and tobacco often report increased depression and anxiety, and why quitting cannabis is harder for them than for people only using cannabis
“This is the first evidence in humans of a molecular mechanism that may underlie why people who use both cannabis and tobacco experience worse outcomes,” said lead author Rachel Rabin, Associate Professor in McGill’s Department of Psychiatry ...
“The major issue is that longevity clinics not yet embedded within mainstream medical practice.”
BUFFALO, NY — October 21, 2025 — A new editorial was published in Aging-US on October 13, 2025, titled “Longevity clinics: between promise and peril.”
In this editorial, Marco Demaria, Editor-in-Chief of Aging-US, from the European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), University ...
The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies. However, the factors and mechanisms that drive this burst in proliferation remain poorly understood, making it difficult to predict which patients will benefit from treatment. A deeper understanding of this T cell burst could also guide the development of new therapies that enhance T cell proliferation and improve treatment outcomes.
To tackle this challenge, an international team of researchers led by Associate Professor Satoshi Ueha and Professor Kouji Matsushima from the Research ...
(WASHINGTON — October 21, 2025) – In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development. These findings provide insight that may help clinicians to anticipate and mitigate adverse pregnancy outcomes and were published in the journal Blood Advances.
“Patients with sickle cell disease are at high risk for developing preeclampsia, but the challenge is that these patients ...
Engineers at the University of California San Diego have created a new method to make large language models (LLMs) — such as the ones that power chatbots and protein sequencing tools — learn new tasks using significantly less data and computing power.
LLMs are made up of billions of parameters that determine how they process information. Traditional fine-tuning methods adjust all of these parameters, which can be costly and prone to overfitting — when a model memorizes patterns instead of truly understanding them, causing it to perform poorly on new examples.
The new method developed by UC San Diego engineers takes a smarter approach. ...
Miami (October 21, 2025) – The Bronchiectasis and NTM Association has accepted eight Care Center and 17 Clinical Associate Center sites in 14 states into the Bronchiectasis and NTM Care Center Network (CCN). The CCN includes 58 centers across the United States.
The CCN aims to facilitate access to specialized care and support for the hundreds of thousands of people with bronchiectasis and nontuberculous mycobacterial (NTM) lung disease.
“The prevalence of bronchiectasis and NTM lung disease continues to increase. Patients deserve access to high-quality, specialized care and resources,” said Doreen Addrizzo-Harris, M.D., Chair of ...
Study involved 160 amputees treated at two hospitals in Ukraine
At one month, botulinum toxin group saw a four-point pain drop versus one point for standard care group
At three months, the trend shifted as effects of botulinum toxin waned
Senior author is a retired U.S. Army colonel and physician who traveled to Ukraine to launch the study and collaborate with local doctors
CHICAGO --- Botulinum toxin injections provided greater short-term relief for phantom limb pain than standard medical and surgical care among Ukrainian war amputees, reports a new study led by Northwestern ...
